Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer
, 2020
Efficacy of regorafenib in the second-and third-line settingfor patients with advanced hepatocellular carcinoma: A reallife data of multicenter study from Turkey
, 2020
Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival.
, 2021
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
, 2020
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
, 2023
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
, 2023
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
, 2022
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study
, 2023
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study
, 2023
Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102
, 2019
Classifying Invasive Lobular Carcinoma as Special Type Breast Cancer May Be Reducing Its Treatment Success: A comparison of Survival Among Invasive Lobular Carcinoma, Invasive Ductal Carcinoma, and No-Lobular Special Type Breast Cancer
, 2023
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study
, 2022
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
, 2022
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Regorafenib or rechallenge chemotherapy: Which is more effective in the third-line treatment of metastatic colorectal cancer?
, 2019
Efficacy of Regorafenib in the Second-and Third-line Settingfor Patients with Advanced Hepatocellular Carcinoma: A RealLife Data of Multicenter Study from Turkey
, 2020
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database
, 2023
Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases
, 2019
Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?
, 2019
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
, 2019
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
, 2022
Prognostic Factors for Survival in Transverse Colon Cancers
, 2022
ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences
, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
, 2022
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
, 2022
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
, 2022
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
, 2022
Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide
, 2022
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
, 2022
Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma
, 2022
Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma
, 2022
Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma
, 2022
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies
, 2022
An experimental study: the effect of S. boulardii on abemaciclib-induced diarrhea
, 2023
Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak
, 2020
Colonic Metastasis from Carcinoma of the Breast that Mimics a Primary Intestinal Cancer
, 2006
Investigation of The Relationship of <i>TNFRSF11A</i> Gene Polymorphisms with Breast Cancer Development and Metastasis Risk in Patients with <i>BRCA1</i> Or <i>BRCA2</i> Pathogenic Variants Living in The Trakya Region of Turkey.
, 2021
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
, 2021
Stage I colon cancer that spreads into a colovesical fistula-mediated bladder due to crohn’s disease: A case report
, 2020
Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis
, 2020
Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience
, 2020
Merkel cell carcinoma in Turkey: A multicentric study
, 2021
Secondary pneumothorax during immunotherapy in two patients with metastatic solid tumors; a new entity
, 2021
Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
, 2021
Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study
, 2020
Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study
, 2020
Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey
, 2020
Genetic screening results of individuals with high risk BRCArelated breast/ovarian cancer in Trakya region of Turkey
, 2020
Investigation of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in patients with colorectal cancer.
, 2021
Clinicopathological and prognostic characteristics of acral metastases in patients with malignant disease: A retrospective study
, 2021
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non\u2013Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
, 2021
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
, 2021
Comparison of skeletal muscle mass loss in patients withmetastatic colorectal cancer treated with regorafenib orTAS-102
, 2019
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
, 2021
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non\u2013Small Cell Lung Cancer
, 2021
Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
, 2021
The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas
, 2020
Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience
, 2021
The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment
, 2021
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma
, 2018
Need for Patient Education and Better Physician-Patient Communication in Melanoma Patients
, 2021
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
, 2018
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
Evaluating Sun Protection Behaviors and Skin Self Examination Practices Among the Family Members of Melanoma Patients in Turkey: A Cross-sectional Survey Study
, 2020
Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib
, 2019
Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer
, 2020
Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study
, 2020
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
, 2018
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
, 2020
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
, 2020
Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib
, 2019
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
, 2020
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma
, 2018
Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis
, 2020
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors
, 2014
Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey
, 2020
Incidence of contrast induced nephropathy in hospitalised patients with cancer
, 2014
Concordance of PD-L1 expression and CD8 TIL intensity between NSCLC and synchronous brain metastases
, 2020
The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas
, 2020
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
, 2019
Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study
, 2020
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer
, 2020
KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer
, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatment
, 2016
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)
, 2019
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
, 2019
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases
, 2019
The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases
, 2019
Endometrial carcinoma and paraneoplastic immune thrombocytopenia
, 2016
Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report
, 2016
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
, 2018
Fatal hepatic veno-occlusive disease in an adult patient with Wilms’xx tumour.
, 2003
Effect of maximum tolerated doses and low dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin 1 levels in patients with advanced nonsmall cell lung cancer
, 2008
Performance Status is an Important Prognostic Factor in Second Line Treatment of Pancreaticobiliary Adenocarcinoma
, 2013
Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience
, 2017
K-RAS and N-RAS mutations in testicular germ cell tumors
, 2017
Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis.
, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
, 2017
K-RAS and N-RAS mutations in testicular germ cell tumors
, 2017
Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma Case report
Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor EGFR mutation
, 2016
Endometrial carcinoma and paraneoplastic immune thrombocytopenia
, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second line treatment
, 2016
Metastatik Küçük Hücreli Dışı Akciğer Kanserinde Kaç Seri Kemoterapi Verilmeli
, 2016
Unknown primary adenocarcinomas a single center experience
, 2016
The effect of the gastrectomy on survival in patients with metastatic gastric cancer a study of ASMO
, 2016
A rare cause in etiology of left atrial mass metastatic testicular germ cell tumor
, 2016
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
, 2016
Unknown primary adenocarcinomas a single center experience
, 2016
Modified docetaxel cisplatin and fluorouracil therapy as the first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study
, 2016
Implantation of central venous ports with chest catheter insertion via the subclavian vein in oncology patients In single center experience
, 2009
Single agent bevacizumab is an effective treatment in recurrent glioblastoma
, 2015
Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancer
, 2015
Comparative analysis of the efficacy and safety of modified FOLFOX 6 and DCF regimens as first line treatment in advanced gastric cancer
, 2015
Increased dose single agent gemcitabine in platinum taxane resistant metastatic ovarian cancer
, 2015
Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5 Fluorouracil Leucovorin Modified FOLFOX6 with Advanced Gastric Cancer Patients having a Good or Poor Performance Status
, 2015
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors
, 2015
Importance of Ki 67 in human epidermal growth factorreceptor 2 positive breast cancer
, 2015
Denosumab a Monoclonal Antibody not a Radionuclide
, 2015
Incidence of contrast induced nephropathy in hospitalised patients with cancer
, 2014
Increased dose single agent gemcitabine in platinum taxane resistant metastatic ovarian cancer
, 2015
Incidence of contrast induced nephropathy in hospitalised patients with cancer
, 2014
Massive Upper Gastrointestinal Bleeding From Pure Metastatic Choriocarcinoma in Patient With Mixed Germ Cell Tumor With Subclinical Intestinal Metastasis
, 2009
The efficiency of single agent docetaxel in patients with platinum refractory non small cell lung carcinoma
, 2008
Ovarian carcinosarcomas Clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum
, 2008
Extrapulmonary small cell carcinoma compared with small cell lung carcinoma
, 2007
Effect of maximum tolerated doses and low dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin 1 levels in patients with advanced nonsmall cell lung cancer
, 2008
Efficient and Safe Application of a FOLFIRI Bevacizumab Combination to a Patient with Locally Advanced Rectal Cancer and Severe Chronic Renal Failure
, 2007
Colonic Metastasis from Carcinoma of the Breast that Mimicks a Primary Intestinal Cancer
, 2006
Isolated Bone Metastasis in Testicular Germ Cell Tumors A Case Report and Review of the Literature
, 2006
Factors affecting the prognosis of breast cancer patients with brain metastases
, 2008
Extrapulmonary small cell carcinoma localized in lymph nodes Is it a different clinical entity
, 2009
The effect of Saccharomyces boulardii on reducing irinotecan induced intestinal mucositis and diarrhea
, 2009
Triple negative breast cancer compared to hormone receptor negative HER2 positive breast cancer
, 2009
Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis
, 2009
The comparison of weekly and three weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non metastatic squamous cell carcinoma of the head and neck
, 2009
Malignant Ovarian Germ Cell Tumors
, 2009
Synchronous Tonsil Gallbladder and Cardiac Metastases without any other Visceral Metastases of Malignant Melanoma
, 2009
Yolk sac tumours of the ovary Evaluation of clinicopathological features and prognostic factors
, 2009
Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI bevacizumab
, 2009
A Case of Malignant Melanoma With Cardiac and Gallbladder Metastases Detected by FDG PET CT
, 2009
Pleomorphic liposarcoma of the pectoralis major muscle in an elderly man Report of a case and review of literature
, 2009
Inflammatory myofibroblastic tumor presenting as an abdominal wall mass in an adult patient
, 2010
Protective effect of l carnitine versus amifostine against cisplatin induced nephrotoxicity in rats
, 2011
Assessment of CA 125 area under the curve as a prognostic factor in patients with ovarian cancer
, 2013
Carnitine or dimethyl sulfoxide or both for the treatment of anthracycline extravasation in rats
, 2013
Medical Treatment of Breast Cancer Bone Metastasis From Bisphosphonates to Targeted Drugs
, 2014
Bildiriler
A case of Treatment and Patient Endometriım Canser Nursing Care - ÇİÇİN İRFAN,TEKBAŞ SERAP,DEDEOĞLU DEMİR BURCU
EFFICACY AND SAFETY OF FOLFIRI/AFLIBERCEPT IN PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER PATIENTS (TOG STUDY)
- EROL CİHAN, HIZAL MUTLU, BİLGETEKİN İREM, akbaş sinem, ŞENER DEDE DİDEM, AKINCI MUHAMMED BÜLENT, YALÇIN BÜLENT, ÇİÇİN İRFAN, ŞENDUR MEHMET ALİ NAHİT, ARTAÇ MEHMET, bayır garipoğlu duygu, bayır garipoğlu duygu, ARSLAN ÇAĞATAY, KÜÇÜKARDA AHMET, ARAZ MURAT
MO31-2 Telisotuzumab vedotin monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer - Horinouchi Hidehito, Goldman J.W., Moiseenko F., ÇİÇİN İRFAN, Filippova E., Bar J., Tomasini P., Ocampo C., Sullivan D., Maag D., Motwani M., Jin J., Camidge D.R.
LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) - Cho B.C., Ahn MJ, Kang JH, Soo R, Yang JCH, ÇİÇİN İRFAN, Kim DW, Wu Y-L., Lu S., Lee K., Pang Y-K., imina A. Z, Fong C.H., Poddubskaya E., Ki Y., An T, Lee H., Byun H., Zaric B.
LBA54 Three years survival outcome and continued cemiplimab (CEMI) beyond progression with the addition of chemotherapy (chemo) for patients (pts) with advanced non-small cell lung cancer (NSCLC): The EMPOWER-Lung 1 trial - ÖZGÜROĞLU MUSTAFA, KILIÇKAP SAADETTİN, SEZER AHMET, GÜMÜŞ MAHMUT, Bondarenko Igor, Gogishvili Miranda, Nechaeva Marina, Schenker Michael, ÇİÇİN İRFAN, Ho G.F., Kulyaba Y., Dvorkin M., Zyuhal K., Scheuasan R.I, Li S., Pouliot J.F., Seebach F., Lovy I., Gullo G., Rietschel P.
Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey. - KILIÇKAP SAADETTİN,Öztürk Akın,KARADURMUŞ NURİ,KORKMAZ TANER,YUMUK PERRAN FULDEN,ÇİÇİN İRFAN,PAYDAŞ SEMRA,ÇILBIR E,Sakalar T,UYSAL MÜKREMİN,ÜSKENT NECDET,Demir N,SAKİN A,TURHAL N S,Keskin S,TURAL DENİZ,ERALP YEŞİM,Basal F,Yaşar H,ŞENDUR MEHMET ALİ NAHİT,DEMİRCİ UMUT,ÇUBUKÇU ERDEM,Karaağaç M,KARACA ŞAZİYE BURÇAK,TATLI ALİ MURAT,YETİŞYİĞİT TARKAN,URVAY SEMİHA,gürsoy p,OYAN ULUÇ BAŞAK,TURNA ZEYNEP HANDE,KÜÇÜKÖNER MEHMET,ÖLMEZ ÖMER FATİH,ÇABUK DEVRİM,ŞEKER MESUT,Ünal O,MEYDAN NEZİH,OKUTUR SADİ KEREM,Tunalı D
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC. - yıldırım mahmut emte, KARACA MUSTAFA, ARTAÇ MEHMET, ÇİÇİN İRFAN, GEREDELİ ÇAĞLAYAN, ALACACIOĞLU AHMET, TANRIKULU ŞİMŞEK EDA, BİLİCİ AHMET, HARPUTLUOĞLU HAKAN, ÖZÇELİK MELİKE, BOZKURT OKTAY, yüksel sinemiş, TURAL DENİZ, SAKİN ABDULLAH, ÇİL TİMUÇİN, ÖVEN BALA BAŞAK, DANE FAYSAL, çevik duygu, GÜMÜŞ MAHMUT, IŞIKDOĞAN ABDURRAHMAN
Geriatrik (≥75 Yaş), Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Hastalarında 1. Basamak Anti- Androjen Tedavi Sonuçları- Gerçek Yaşam Verisi - ALKAN ALİ, GÜÇ ZEYNEP GÜLSÜM, GÜRBÜZ MUSTAFA, ÖZGÜN GÜLİZ, DEĞİRMENCİOĞLU SERKAN, DOĞAN MUTLU, AKIN TELLİ TUĞBA, KESKİN ÖZGE, ARSLAN ÇAĞATAY, BİLGİN BURAK, SEZGİN GÖKSU SEMA, DEMİR HACER, KÖKSOY ELİF BERNA, KÖSTEK OSMAN, ERTÜRK İSMAİL, ŞAKALAR TEOMAN, KARAOĞLU AZİZ, ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA, YUMUK PERRAN FULDEN, ŞENDUR MEHMET ALİ NAHİT, COŞKUN HASAN ŞENOL, ÇİÇİN İRFAN, KARADURMUŞ NURİ, TANRIVERDİ ÖZGÜR, AKBULUT HAKAN, ÜRÜN YÜKSEL
Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçlari- Gerçek Yaşam Verisi - ALKAN ALİ, GÜÇ ZEYNEP GÜLSÜM, GÜRBÜZ MUSTAFA, ÖZGÜN GÜLİZ, DEĞİRMENCİOĞLU SERKAN, DOĞAN MUTLU, AKIN TELLİ TUĞBA, KESKİN ÖZGE, ARSLAN ÇAĞATAY, BİLGİN BURAK, SEZGİN GÖKSU SEMA, DEMİR HACER, KÖKSOY ELİF BERNA, KÖSTEK OSMAN, ERTÜRK İSMAİL, ŞAKALAR TEOMAN, KARAOĞLU AZİZ, ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA, YUMUK PERRAN FULDEN, ŞENDUR MEHMET ALİ NAHİT, COŞKUN HASAN ŞENOL, ÇİÇİN İRFAN, KARADURMUŞ NURİ, TANRIVERDİ ÖZGÜR, AKBULUT HAKAN, ÜRÜN YÜKSEL
PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY) - EROL CİHAN, HIZAL MUTLU, BİLGETEKİN İREM, AKBAŞ SİNEM, GARBİOĞLU DUYGU BAYIR, HAMDARD JAMSHID, ARSLAN ÇAĞATAY, SEVİNÇ ALPER, KÜÇÜKARDA AHMET, GÜRGENYATAĞI DİLEK, ÇAKIR EMRE, DEMİRKIRAN AYKUT, ARAZ MURAT, ÖN SERCAN, DOĞAN İZZET, ERDOĞAN ATİKE PINAR, KOCA SİNAN, KUBİLAY PINAR, EREN ORHAN ÖNDER, ÖZYÜKSELER DENİZ TATAROĞLU, YILDIRIM MAHMUT EMRE, ÇILBIR EBRU, ÇELİK EMİR, BAHÇECİ AYKUT, TAŞKAYNATAN HALİL, OYMAN ABDÜLKERİM, DENİZ GÜLHAN İPEK, MENEKŞE SERKAN, KUT ENGİN, GÜLMEZ AHMET, SAKİN ABDULLAH, NAYIR ERDİNÇ, ACAR RAMAZAN, KAHRAMAN SEDA, ŞEN ERDEM, İNAL ALİ, TURHAL NAZIM SERDAR, KAYA ALİ OSMAN, PAYDAŞ SEMRA, TAŞTEKİN DİDEM, HACIBEKİROĞLU İLHAN, ÇİÇİN İRFAN, BİLİCİ AHMET, ŞENER DEDE DİDEM, AKINCI MUHAMMED BÜLENT, MANDEL NİL MOLİNAS, ÖKSÜZOĞLU BERNA, UNCU DOĞAN, YALÇIN BÜLENT, ARTAÇ MEHMET, ŞENDUR MEHMET ALİ NAHİT
Efficacy of crizotinib in patients with ALK positive advanced stage non-small cell lung cancer: A real-world experience from Turkey - KILIÇKAP SAADETTİN, GÜRSOY PINAR, BUĞDAYCI BAŞOL FATMA, ÇAM ARZU, DEMİRCİ UMUT, ALAN ÖZKAN, TATLI ALİ MURAT, ÖZTÜRK AKIN, ÇUBUKÇU ERDEM, ÇİÇİN İRFAN, KARAAĞAÇ MUSTAFA, KÜÇÜKÖNER MEHMET
Is there any prognostic significance in pleural involvement and/oreffusion (Ple-I/E) in patients with ALK-positive NSCLC? - KILIÇKAP SAADETTİN, BUĞDAYCI BAŞAL FATMA, DEMİRKAZIK AHMET, GÜRSOY PINAR, DEMİRCİ UMUT, ERMAN MUSTAFA, YUMUK PERRAN FULDEN, ŞENLER FİLİZ ÇAY, ÇAKAR BURCU, ÇİÇİN İRFAN, ÖZTÜRK AKIN, COŞKUN HASAN ŞENOL, ÇUBUKÇU ERDEM, IŞIKDOĞAN ABDURRAHMAN, ÖLMEZ ÖMER FATİH, TATLI ALİ MURAT, KARAAĞAÇ MUSTAFA, ŞAKALAR TEOMAN, ERALP YEŞİM, KORKMAZ TANER
PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY) - EROL CİHAN,HIZAL MUTLU,BİLGETEKİN İREM,AKBAŞ SİNEM,GARİPOĞLU DUYGU BAYIR,HAMDARD JAMSHİD,ARSLAN ÇAĞATAY,SEVİNÇ ALPER,KÜÇÜKARDA AHMET,GÜRGENYATAĞI DİLEK,ÇAKIR EMRE,DEMİRKIRAN AYKUT,ARAZ MURAT,ÖN SERCAN,DOĞAN İZZET,ERDOĞAN ATİKE PINAR,KOCA SİNAN,KUBİLAY PINAR,EREN ORHAN ÖNDER,ÖZYÜKSELER DENİZ TATAROĞLU,YILDIRIM MAHMUT EMRE,ÇILBIR EBRU,ÇELİK EMİR,BAHÇECİ AYKUT,TAŞKAYNATAN HALİL,OYMAN ABDÜLKERİM,DENİZ GÜLHAN İPEK,MENEKŞE SERKAN,KUT ENGİN,GÜLMEZ AHMET,SAKİN ABDULLAH,NAYIR ERDİNÇ,ACAR RAMAZAN,KAHRAMAN SEDA,ŞEN ERDEM,İNAL ALİ,TURHAL SERDAR,KAYA ALİ OSMAN,PAYDAŞ SEMRA,TAŞTEKİN DİDEM,HACIBEKİROĞLU İLHAN,ÇİÇİN İRFAN,BİLİCİ AHMET,ŞENER DEDE DİDEM,AKINCI MUHAMMED BÜLENT,MANDEL NİL KLER,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,UNCU DOĞAN,YALÇIN BÜLENT,ARTAÇ MEHMET,ŞENDUR MEHMET ALİ NAHİT
Birinci Basamak İmmünoterapi Alan Metastatik Küçük Hücreli Dışı Akciğer Kanseri Hastalarında Yanıt Derinliği ile Yanıt Dayanıklılığı ve Genel Sağkalım İlişkisi - GÖKYER ALİ,KÜÇÜKARDA AHMET,ÇİÇİN İRFAN
Association of The Role of Cytochrome P4501a1 Gene Polymorphism In Colorectal Cancer - AY ARZU,ALKANLI NEVRA,GÜLYAŞAR TEVFİK,SİPAHİ TAMMAM,ÇİÇİN İRFAN,KOÇAK ZAFER
EFFICACY AND SAFETY OF FOLFIRI/AFLIBERCEPTIN PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER PATIENTS (TOG STUDY) - EROL CİHAN,HIZAL MUTLU,BİLGETEKİN İREM,AKBAŞ SİNEM,GARİPOĞLU DUYGU,HAMDARD JAMSHİD,ARSLAN ÇAĞATAY,SEVİNÇ ALPER,KÜÇÜKARDA AHMET,KAHRAMAN SEDA,GÜRGENYATAĞI DİLEK,ÇAKIR EMRE,DEMİRKIRAN AYKUT,ARAZ MURAT,ÖN SERCAN,DOĞAN İZZET,ERDOĞAN ATİKE PINAR,KOCA SİNAN,KUBİLAY PINAR,EREN ORHAN ÖNDER,ÖZYÜKSELER DENİZ TATAROĞLU,YILDIRIM MAHMUT EMRE,ÇILBIR EBRU,ÇELİK EMİR,BAHÇECİ AYKUT,TAŞKAYNATAN HALİL,OYMAN ABDÜLKERİM,DENİZ GÜLHAN İPEK,MENEKŞE SERKAN,KUT ENGİN,GÜLMEZ AHMET,SAKİN ABDULLAH,NAYIR ERDİNÇ,ACAR RAMAZAN,ŞEN ERDEM,İNAL SALİH,TURHAL SERDAL,KAYA ALİ OSMAN,PAYDAŞ SEMRA,TAŞTEKİN DİDEM,HACIBEKİROĞLU İLHAN,ÇİÇİN İRFAN,BİLİCİ AHMET,ŞENER DEDE DİDEM,AKINCI MUHAMMED BÜLENT,MANDEL NİL KLER,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,UNCU DOĞAN,YALÇIN BÜLENT,ŞENDUR MEHMET ALİ NAHİT,ARTAÇ MEHMET
Association Of Glutatyon S Transferaz M1 Gene Polimorphism Genotypes And Serum Iron Levels In Colorectal Cancer - AY ARZU,ALKANLI NEVRA,GÜLYAŞAR TEVFİK,SİPAHİ TAMMAM,ÇİÇİN İRFAN,KOÇAK ZAFER
Investigation of GSTM1 polymorphism genotypes and serum trace elements in colorectal cancer - AY ARZU,ALKANLI NEVRA,GÜLYAŞAR TEVFİK,SİPAHİ TAMMAM,ÇİÇİN İRFAN
Kolorektal Kanserli Hastalarda Sitokrom P4501A1 (rs:1048943) Gen Polimorfizminin Araştırılması - AY ARZU,ALKANLI NEVRA,GÜLYAŞAR TEVFİK,SİPAHİ TAMMAM,ÇİÇİN İRFAN,KOÇAK ZAFER,SÜT NECDET
Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA). - ÖZASLAN ERSİN, ÖZKAN METİN, ÇİÇİN İRFAN, BENEKLİ MUSTAFA, KOÇER MURAT, UYSAL MÜKREMİN, ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA, IŞIKDOĞAN ABDURRAHMAN, ÇUBUKÇU ERDEM, ELKIRAN EMİN TAMER, DANE FAYSAL, ALİUSTAOĞLU MEHMET, SEVİNÇ ALPER, KARAOĞLU AZİZ, ULAŞ ARİFE, GÖKÖZ DOĞU GAMZE
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wi̇ld-type patients treated with biologics first-line metastatic colorectal cancer - KEFELİ UMUT, BİLİR CEMİL, ŞENDUR MEHMET ALİ NAHİT, IŞIKDOĞAN ABDURRAHMAN, DANE FAYSAL, ÇİÇİN İRFAN, GÜMÜŞ MAHMUT
LBA52 EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50% - SEZER AHMET, KILIÇKAP SAADETTİN, GÜMÜŞ MAHMUT, Bondarenko Ivan, ÖZGÜROĞLU MUSTAFA, Gogishvili Mic, TÜRK HACI MEHMET, ÇİÇİN İRFAN, Bentsion Den, Gladkov Oleg, Clingan Pet, Sriuranpong Vvv, Rizvi Nnn, Li Sss, Lee Sss, Gullo Guiseppe, Lowy Igor, Rietschel Petricia
PROGNOSTIC AND PREDICTIVE MARKERS
OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH
METASTATIC COLORECTAL CANCER (TOG STUDY)
Cihan Erol1
, Mutlu Hızal2
, Irem Bilgetekin3
, Sinem Akbas4
,
Duygu Bayir Garbioglu5
, Jamshid Hamdard6
, Cagatay Arslan7
,
Alper Sevinc8
, Ahmet Kucukarda9
, Dilek Gurgenyatagi10, Emre
Cakir11, Aykut Demirkiran12, Murat Araz12, Sercan On13, Izzet
Dogan14, Atike Pinar Erdogan15, Sinan Koca16, Pinar Kubilay17,
Onder Eren18, Deniz Tataroglu Ozyukseler19, Mahmut Emre
Yildirim19, Ebru Cilbir20, Emir Celik21, Aykut Bahceci22, Halil
Taskaynatan23, Abdulkerim Oyman24, Gulhan Ipek Deniz25,
Serkan Menenekse26, Engin Kut26, Ahmet Gulmez27, Abdullah
Sakin28, Erdinc Nayir29, Ramazan Acar30, Seda Kahraman1
,
Erdem Sen31, Ali Inal32, Serdar Turhal33, Ali Osman Kaya34, Semra
Paydas35, Didem Tastekin14, Ilhan Hacıbekiroglu11, Irfan Cicin9
,
Ahmet Bilici6
, Didem Sener Dede1
, Muhammed Bulent Akinci1
,
Nil Molinas Mandel36, Berna Oksuzoglu3
, Dogan Uncu2
, Bulent
Yalcin1
, Mehmet Artac12, Mehmet Ali Nahit Sendur1 - EROL CİHAN, HIZAL MUTLU, BİLGETEKİN İREM, akbaş sinem, ÇİÇİN İRFAN, ŞENER DEDE DİDEM, AKINCI MUHAMMED BÜLENT, YALÇIN BÜLENT, ŞENDUR MEHMET ALİ NAHİT
The Efficacy and Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC: The Real-world Experience from Turkey - KILIÇKAP SAADETTİN,ÖLMEZ ÖMER FATİH,ÇİÇİN İRFAN,DEMİRCİ UMUT,ALAN ÖZKAN,ÇABUK DEVRİM,ŞAKALAR TEOMAN,TATLI ALİ MURAT,BUĞDAYCI BAŞOL FATMA,ERALP YEŞİM,UYSAL MÜKREMİN,DEMİRKAZIK AHMET,BİLGİN BURAK,YILDIZ BİROL,KARAAĞAÇ MUSTAFA,OKUTUR SADİ KEREM,SAKİN ABDULLAH
Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC) - Miksad Rebecca,ÇİÇİN İRFAN,Chen YenHsun,Klümpen Heinz Josef,Kim Stefeno,Youkstetter Jillian,Sen Suvajit,Cheng AnnLii,ElKhoueiry Anthony B,Meyer Tim,Kelley Robin Kate,AbouAlfa Ghassan K
Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged = 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS - Shitara Kohei,Doi Toshihiko,Hosaka Hisashi,Thuss-Patience Peter C,Santoro Armando,Jiménez-Fonseca Paula,Longo Federico,Ozyilkan Ozgur,ÇİÇİN İRFAN,Park David,Park David,Zaanan Aziz,Bilancia Domenico,Pericay Carles,Ozguroglu Mustafa,ALSINA MARIA,Makris Lukas,McGuigan Sandra,Ilson David H
P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey - KILIÇKAP SAADETTİN,DEMİRCİ UMUT,BUĞDAYCI F,TURAL DENİZ,KORKMAZ TANER,PAYDAŞ SEMRA,YILMAZ C,TURNA ZEYNEP HANDE,Sezer Atakan,YEŞİL ÇİNKİR H,OKUTUR SADİ KEREM,ERMAN MUSTAFA,ERALP YEŞİM,ÇABUK DEVRİM,IŞIKDOĞAN ABDURRAHMAN,DEMİRKAZIK AHMET,KARAOĞLU AZİZ,YAZILITAŞ D,ÇAY ŞENLER FİLİZ,YUMUK PERRAN FULDEN,COŞKUN HASAN ŞENOL,YILDIZ İBRAHİM,ÖZTOP İLHAN,BEYPINAR I,AYDIN K,KAPLAN MUHAMMET ALİ,MEYDAN NEZİH,ÖLMEZ ÖMER FATİH,ÖZYILKAN ÖZGÜR,ŞEBER ERDOĞAN SELÇUK,ARSLAN ÇAĞATAY,ŞENDUR MEHMET ALİ NAHİT,ÇİÇİN İRFAN
1547 P: Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC? - KILIÇKAP SAADETTİN,BUĞDAYCI BAŞAL F,DEMİRKAZIK AHMET,GÜRSOY P,DEMİRCİ UMUT,ERMAN MUSTAFA,YUMUK PERRAN FULDEN,ÇAY ŞENLER FİLİZ,ÇAKAR BURCU,ÇİÇİN İRFAN,Öztürk Akın,COŞKUN HASAN ŞENOL,ÇUBUKÇU ERDEM,IŞIKDOĞAN ABDURRAHMAN,ÖLMEZ ÖMER FATİH,TATLI ALİ MURAT,KARAAĞAÇ MUSTAFA,ŞAKALAR TEOMAN,ERALP YEŞİM,KORKMAZ TANER
Real-world assessment of clinical effectiveness and safety ofpazopanib in patients with advanced or metastatic renal cellcarcinoma (RCC) in Asia, North Africa and Middle East countries: Aprospective, observational study (PARACHUTE) - Kanesvaran R,,Biswas B,,Danchaivijitr P,,Lim C,S,,KARABULUT BÜLENT,Wong Y,F,,COŞKUN HASAN ŞENOL,Chang C,,ÇİÇİN İRFAN,İngles S,,Slimane K,,ERMAN MUSTAFA
Real-world assessment of clinical effectiveness and safety ofpazopanib in patients with advanced or metastatic renal cellcarcinoma (RCC) in Asia, North Africa and Middle East countries: Aprospective, observational study (PARACHUTE) - Kanesvaran R,,Biswas B,,Danchaivijitr P,,Lim C,S,,KARABULUT BÜLENT,Wong Y,F,,COŞKUN HASAN ŞENOL,Chang C,,ÇİÇİN İRFAN,İngles S,,Slimane K,,ERMAN MUSTAFA
Real-world assessment of clinical effectiveness and safety ofpazopanib in patients with advanced or metastatic renal cellcarcinoma (RCC) in Asia, North Africa and Middle East countries: Aprospective, observational study (PARACHUTE) - Kanesvaran R,,Biswas B,,Danchaivijitr P,,Lim C,S,,KARABULUT BÜLENT,Wong Y,F,,COŞKUN HASAN ŞENOL,Chang C,,ÇİÇİN İRFAN,İngles S,,Slimane K,,ERMAN MUSTAFA
Real-world assessment of clinical effectiveness and safety ofpazopanib in patients with advanced or metastatic renal cellcarcinoma (RCC) in Asia, North Africa and Middle East countries: Aprospective, observational study (PARACHUTE) - Kanesvaran R,,Biswas B,,Danchaivijitr P,,Lim C,S,,KARABULUT BÜLENT,Wong Y,F,,COŞKUN HASAN ŞENOL,Chang C,,ÇİÇİN İRFAN,İngles S,,Slimane K,,ERMAN MUSTAFA
Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC? - KILIÇKAP SAADETTİN,DEMİRKAZIK AHMET,GÜRSOY PINAR,DEMİRCİ UMUT,ERMAN MUSTAFA,YUMUK PERRAN FULDEN,ÇAY ŞENLER FİLİZ,ÇAKAR BURCU,ÇİÇİN İRFAN,ÖZTÜRK AKIN,COŞKUN HASAN ŞENOL,ÇUBUKÇU ERDEM,IŞIKDOĞAN ABDURRAHMAN,ÖLMEZ ÖMER FATİH,TATLI ALİ MURAT,KARAAĞAÇ MUSTAFA,ŞAKALAR TEOMAN,ERALP YEŞİM,KORKMAZ TANER
Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi - ALKAN ALİ,SEVGEN GÜÇ ZEYNEP,GÜRBÜZ MUSTAFA,ÖZGÜN GÜLİZ,DEĞİRMENCİOĞLU SERKAN,DOĞAN MUTLU,AKIN TELLİ TUĞBA,KESKİN ÖZGE,ARSLAN ÇAĞATAY,BİLGİN BURAK,SEZGİN GÖKSU SEMA,DEMİR HACER,KÖKSOY ELİF BERNA,KÖSTEK OSMAN,ERTÜRK İSMAİL,ŞAKALAR TEOMAN,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,YUMUK PERRAN FULDEN,ŞENDUR MEHMET ALİ NAHİT,COŞKUN HASAN ŞENOL,ÇİÇİN İRFAN,KARADURMUŞ NURİ,TANRIVERDİ ÖZGÜR,AKBULUT HAKAN,ÜRÜN YÜKSEL
The efficacy and safety of crizotinib in patients with ROS1 positiveadvanced stage NSCLC: The real-world experience from Turkey - KILIÇKAP SAADETTİN,ÖLMEZ ÖMER FATİH,ÇİÇİN İRFAN,DEMİRCİ UMUT,ALAN ÖZKAN,ÇABUK DEVRİM,ŞAKALAR TEOMAN,TATLI ALİ MURAT,BAŞOL BUĞDAYCI FATMA,ERALP YEŞİM,UYSAL MÜKREMİN,DEMİRKAZIK AHMET,BİLGİN BURAK,YILDIZ BİROL,KARAAĞAÇ MUSTAFA,OKUTUR SADİ KEREM,SAKİN ABDULLAH
Assessment of Tumor Response, AFP Response, and Time to Progression in the Phase 3 CELESTIAL Trial of Cabozantinib Versus Placebo in Advanced Hepatocellular Carcinoma - Merle Philippe,Rimassa Lorenza,Ryoo Baek Yeol,ÇİÇİN İRFAN,Harris William P,Banu Eugeniu,Sarker Debashis,Tan Benjamin,Vlierberghe Hans Van,Sen Suvajit,Love Celeste,Cheng AnnLii,Meyer Tim,Kelley Robin Kate,AbouAlfa Ghassan K
Health-Related Quality of Life (HRQoL) for Pembrolizumab or Placebo Plus Carboplatin and Paclitaxel or Nab-paclitaxel in Patients With Metastatic Squamous NSCLC: Data From KEYNOTE-407 - Mazieres Julien,Kowalski Dariusz,Luft Alexander,Vicente David,Tafreshi Ali,GÜMÜŞ MAHMUT,Laktionov Konstantin,Hermes Barbara,ÇİÇİN İRFAN,RodrguezCid Jernimo,wilson Janothan,Kato Terufumi,Ramlau Rodryg,Novello Silvia,Reddy Sreekanth,Piperdi Bilal,Li Xiaodong,Burke Thomas,PazAres Luis
Choice of Taxane and Outcomes in the KEYNOTE-407Study of Pembrolizumab Plus Chemotherapy forMetastatic Squamous NSCLC - halmos balazs,Luft Alexander,Majem Margarita,Hui Rina,Corre Romain,GÜMÜŞ MAHMUT,Laktionov Konstantin,Hermes Barbara,ÇİÇİN İRFAN,Robinson Andrew G,Kato Terufumi,Cheng Ying,Kowalski Dariusz,Li Xiaodong,Lubiniecki Gregory M,Piperdi Bilal,PazAres Luis
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial. - K AbouAlfa Ghassan,Meyer Tim,Cheng AnnLii,ElKhoueiry Anthony B,Lorenza , Rimassa,Ryoo Baek Yeol,ÇİÇİN İRFAN,Merle Philippe,Park Joong Won,Blanc Jean Frdric,Bolondi Luigi,Klümpen Heinz Josef,Cha Stephen Lam,Dadduzio Vincenzo,Borgman Anne E,Schwab Gisela,Kelley Robin Kate
Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results - Esin Ece,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,BİLİCİ AHMET,ÇİÇİN İRFAN,AKSOY SERCAN,ALACACIOĞLU AHMET,KAPLAN MUHAMMET ALİ,ÇABUK DEVRİM,SÜMBÜL AHMET TANER,PAYDAŞ SEMRA,Sakin Abdullah,KORKMAZ TANER,ÖZDEMİR NURİYE,ARTAÇ MEHMET,HARPUTLUOĞLU HAKAN,YUMUK PERRAN FULDEN,BAŞARAN GÜL,OYAN ULUÇ BAŞAK,DEMİRCİ UMUT
The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. - Kılıçkap Saadettin,ÖLMEZ ÖMER FATİH,ÇİÇİN İRFAN,DEMİRCİ UMUT,Alan O,ÇABUK DEVRİM,Sakalar Teoman,TATLI ALİ MURAT,Buğdaycı Başal Fatma,Eralp Yeşim,UYSAL MÜKREMİN,DEMİRKAZIK AHMET,Bilgin Burak,Yıldız Birol,KARAAĞAÇ MUSTAFA,Okutur Kerem Sadi,Sakin Abdullah
Does the PD-L1 Status and TIL Intensity Change in NSCLC and Syncronous Brain Metastases? P2.02-073a - ÖZ AYŞİM BÜGE,Durak S,Batur S,YUMUK PERRAN FULDEN,Çağlar HB,BOZKURTLAR EMİNE,BOZKURT SÜHEYLA,TAŞTEKİN EBRU,ÇİÇİN İRFAN,AHISKALI ASİYE RENGİN,Rzazade R,Cakır A
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial. - AbouAlfa Ghassan K,Meyer Tim,Lii Cheng Ann,ElKhoueiry Anthony,Rimassa Lorenza,Yeol Ryoo Baek,ÇİÇİN İRFAN
P1. 01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey - KILIÇKAP SAADETTİN,KARADURMUŞ NURİ,KORKMAZ TANER,YUMUK PERRAN FULDEN,ÇİÇİN İRFAN,PAYDAŞ SEMRA,çılbır ebru,ŞAKALAR TEOMAN,UYSAL MÜKREMİN,ÜSKENT NECDET,DEMİR ATAKAN
Crizotinib Efficacy in ALK-Positive Advanced StageNon-Small Cell Lung Cancer Patients: A Real-WorldExperience from Turkey - KILIÇKAP SAADETTİN,öztürk Akın,KARADURMUŞ NURİ,KORKMAZ TANER,YUMUK PERRAN FULDEN,ÇİÇİN İRFAN,PAYDAŞ SEMRA,Çılbır Ebru,ŞAKALAR TEOMAN,UYSAL MÜKREMİN,üskent necdet,demir necla,sakin abdullah,Turhal Nazım Serdal,keskin serkan,TURAL DENİZ,eralp yeşim,Buğdaycı Fatma,YAŞAR HATİME ARZU,ŞENDUR MEHMET ALİ NAHİT,DEMİRCİ UMUT,ÇUBUKÇU ERDEM
Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC). - Rimassa Lorenza,ÇİÇİN İRFAN
Screening for germline variations of cancer related genes in patients with the diagnosis of different cancers and hereditary cancer predisposition syndromes - DEMİR SELMA,TOZKIR HİLMİ,GÜRKAN HAKAN,ATLI ENGİN,EKER DAMLA,TEZEL HÜSEYİN AHMET,SEZER YAVUZ ATAKAN,ÇİÇİN İRFAN,KARLIKAYA HAYDAR CELAL,KARAMUSTAFAOĞLU YEKTA ALTEMUR
An open-label, Multinational, Phase IIIb Study to Evaluate Patient andSatisfaction, Safety and Efficacy of Subcutaneous Administration ofTrastuzumab in Patients With HER2-Positive Early Breast Cancer(ML28851) in Adjuvant/Neo-Adjuvant Setting - ÇİÇİN İRFAN,Oukkal M,Hassen Mahfou,LARBAOUI Blaha,Errihani Hassan,belbaraka rhizlane,AMEL MEZLINI,benahmed slim,USLU RÜÇHAN,Göktaş Burce,ÖZGÜROĞLU MUSTAFA
Characteristics of Turkish colorectal cancer patients and bevacizumab preference. - ÇİÇİN İRFAN,GÜMÜŞ MAHMUT,UNCU DOĞAN,ÖZKAN METİN,KILIÇKAP SAADETTİN,ELKIRAN EMİN TAMER,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ,TURNA ZEYNEP HANDE,KARA İSMAİL OĞUZ,ÖZYILKAN ÖZGÜR,GÜDÜCÜ MERVE,ERDOĞAN ALPER,USLU RÜÇHAN
Outcomes of Turkish National Breast Cancer Registry. - KILIÇKAP SAADETTİN,GÜMÜŞ MAHMUT,UNCU DOĞAN,ÖZKAN METİN,ÇİÇİN İRFAN,ELKIRAN EMİN TAMER,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ,TURNA ZEYNEP HANDE,USLU RÜÇHAN,ÖZYILKAN ÖZGÜR,ERDOĞAN ALPER,GÖKTAŞ BURÇE,KARA İSMAİL OĞUZ
Outcomes of Turkish National Breast Cancer Registry - KILIÇKAP SAADETTİN,GÜMÜŞ MAHMUT,UNCU DOĞAN,ÖZKAN METİN,ÇİÇİN İRFAN,ELKIRAN EMİN TAMER,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ,TURNA ZEYNEP HANDE,USLU RÜÇHAN,ÖZYILKAN ÖZGÜR,ERDOĞAN ALPER,Göktaş Burce,KARA İSMAİL OĞUZ
Yeni Nesil Klinik Çalışmalar - ÇİÇİN İRFAN
Türkiye’de Faz Çalışmaları - ÇİÇİN İRFAN
Characteristics of Turkish colorectal cancer patients and bevacizumab preference - ÇİÇİN İRFAN,GÜMÜŞ MAHMUT,UNCU DOĞAN,ÖZKAN METİN,KILIÇKAP SAADETTİN,ELKIRAN EMİN TAMER,Isikdogan Abdurrahman,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ,TURNA ZEYNEP HANDE,KARA İSMAİL OĞUZ,ÖZYILKAN ÖZGÜR,USLU RÜÇHAN
Outcomes of Turkish National Breast Cancer Registry. - KILIÇKAP SAADETTİN,GÜMÜŞ MAHMUT,UNCU DOĞAN,ÖZKAN METİN,ÇİÇİN İRFAN,ELKIRAN EMİN TAMER,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ
EFFECTIVENESS AND SAFETY OF LMWH TREATMENT IN CANCER PATIENTS DIAGNOSED WITH NON-HIGH RISK VENOUS THROMBOEMBOLISM (VTE) - RESULTS OF TURKISH OBSERVATIONAL STUDY (TREBECA) - ÖZASLAN ERSİN,ÖZKAN METİN,ÇİÇİN İRFAN,BENEKLİ MUSTAFA,KOÇER MURAT,UYSAL MÜKREMİN,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,IŞIKDOĞAN ABDURRAHMAN,ÇUBUKÇU ERDEM,ELKIRAN EMİN TAMER,DANE FAYSAL,ALİUSTAOĞLU MEHMET,SEVİNÇ ALPER,KARAOĞLU AZİZ,ULAŞ ARİFE,DOĞU GAMZE GÖKOZ
Sınırlı evre küçük hücreli akciğer kanserinde kemoradyoterapi sonuçları - ÖZEN ALAATTİN,ÇUKURÇAYIR FUNDA,İBİŞ KAMURAN,UZUNOĞLU SERNAZ,ÇELİK DENİZ,ÇİÇİN İRFAN,SAYNAK MERT,KOÇAK ZAFER
Turkish National Breast Cancer Registry - ALTUNDAĞ MUSTAFA KADRİ,Dumanlı Esra,Aliustaoğlu Mehmety,Uncu Doğan,ÖZKAN METİN,ÇİÇİN İRFAN,COŞKUN UĞUR,ELKIRAN EMİN TAMER,KOÇER MURAT,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,Başol Tekin Salim,Avcı Nilüfer,Ulaş Arife,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,ÖZDEMİR FEYYAZ,KILIÇKAP SAADETTİN,GÜMÜŞ MAHMUT,BÜYÜKBERBER SÜLEYMAN,BENEKLİ MUSTAFA,DANE FAYSAL,SEVİNÇ ALPER,BÖRÜBAN MELİH CEM,Uslu Rüçhan,ÖZYILKAN ÖZGÜR,YALÇIN BÜLENT,KARA İSMAİL OĞUZ,GÖKÖZ DOĞU GAMZE,ÖZTÜRK BANU,Kaya Ali Osman
Karşılaştırılamayan biyolojik ajanlar Ne biliyoruz - ÇİÇİN İRFAN
Aflibercept plus FOLFIRI for 2nd line treatment of metastatic colorectal cancer mCRC Long term safety observation from the global aflibercept safety and quality of life QoL program ASQoP - R Riechelmann,Srimuninnimit V,Kavan P,Bartolomeo M Dİ,Maiello E,ÇİÇİN İRFAN,Kröning H,GarciaAlfonso P,Chau I,FernndezMartos C,TerOvanesov M,Peeters M,Picard P,Bordonaro R
KANSER HASTALARINDA KONTRASTLI BiLGiSAYARLITOMOGRAFi ÇEKİMİ SONRASI KONTRAST MADDENEFROPATiSi GELİŞME RiSKi VE PREDİKTiFFAKTORLER ÇALIŞMASI FiNAL SONUCLARI - TÜRKMEN ESMA,ERDOĞAN BÜLENT,UZUNOĞLU SERNAZ,KODAZ HİLMİ,ÇİÇİN İRFAN
Association of age with breast cancer clinical and pathological factors Analysis of Turkish National Breast Cancer Registry - BENEKLİ MUSTAFA,ALTUNDAĞ MUSTAFA KADRİ,ESRA DUMANLI,IŞIKDOĞAN ABDURRAHMAN,KARAOĞLU AZİZ,TEKİN SALİM BAŞOL,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,BÖRÜBAN MELİH CEM,KOÇER MURAT,SEVİNÇ ALPER,ÇİÇİN İRFAN
Aflibercept plus FOLFIRI for 2nd line treatment of metastaticcolorectal cancer mCRC Long term safety observation fromthe global aflibercept safety and quality of life QoL program ASQoP - ÇİÇİN İRFAN
REKÜRREN GLİOBLASTOMA TEDAVİSİNDE TEK AJAN BEVACİZUMAB - HACIBEKİROĞLU İLHAN,KODAZ HİLMİ,TÜRKMEN ESMA,ERDOĞAN BÜLENT,ÖZÇELİK MELİKE,ESENKAYA ASIM,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN
Memenin Primer Nöroendokrin Tümörü - SEZER YAVUZ ATAKAN,YAĞCI MEHMET ALİ,YELDAN EYÜP,ALTAN AYDIN,YALÇIN ÖMER,ÇİÇİN İRFAN
The Relationship between Selenium Levels and Genotypes of the Cytochrome P450 1A1 Gene Polymorphisms in Colorectal Cancer - AY ARZU,GÜLYAŞAR TEVFİK,ALKANLI NEVRA,SİPAHİ TAMMAM,ÇİÇİN İRFAN,KOÇAK ZAFER
Low molecular weight heparin LMWH treatment in cancer patients with low risk venous thromboembolism results of Turkish Observational Study TREBECA - ÖZKAN METİN,ÇİÇİN İRFAN,ÖZASLAN ERSİN,BENEKLİ MUSTAFA,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,KOÇER MURAT,IŞIKDOĞAN ABDURRAHMAN,SEVİNÇ ALPER,KARAOĞLU AZİZ,DANE FAYSAL,ÇUBUKÇU ERDEM,ELKIRAN EMİN TAMER,ALİUSTAOĞLU MEHMET
Low molecular weight heparin LMWH treatment in cancer patients with low risk venous thromboembolism results of Turkish Observational Study TREBECA - ÖZKAN METİN,ÇİÇİN İRFAN,ÖZARSLAN ERSİN,BENEKLİ MUSTAFA,ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA,KOÇER MURAT
Effect of body mass index in gastric cancer patients Analysis of Turkish national gastric cancer registry - ÇİÇİN İRFAN
Turkish National Breast Cancer Registry - ÇİÇİN İRFAN
Turkish National Colon Cancer Registry - ÇİÇİN İRFAN
Turkish National Gastric Cancer Registry - ÇİÇİN İRFAN
Effect of body mass index in gastric cancer patients Analysis of Turkish national gastric cancer registry - ÇİÇİN İRFAN
Erken evre meme kanserinde primer KT mi primer cerrahi mi - ÇİÇİN İRFAN
Orijinal Biyolojik Ürün veya Biyobenzer Ürünle Yapılan Klinik Çalışmalar Farklı mıdır Hedef Kanser 2015 02 Nisan 20015 - ÇİÇİN İRFAN
Meme Kanseri sözel bildiri tartışmacılığı tedavi konuşmacı 22 26 Nisan 2015 Antalya - ÇİÇİN İRFAN
Kolon Kanseri Adjuvan Tedavisinde Farmakogenomik veriler ilerisi için umut olabilir mi konuşmacı 14 Mart 2015 Çeşme - ÇİÇİN İRFAN
Biyobenzerler konuşmacı - ÇİÇİN İRFAN
Trakya Bölgesi ndeki Kolorektal Kanserli Hastalarda Glutatyon S Transferaz Gen Polimorfizminin Araştırılması - AY ARZU,ALKANLI NEVRA,GÜLYAŞAR TEVFİK,SİPAHİ TAMMAM,ÇİÇİN İRFAN,KOÇAK ZAFER
Aktif Sigara İçiciliği EGFR Mutant Akciğer Adenokanseri Hastalarında Kötü Bir Prognostik Faktördür - ERDOĞAN BÜLENT,KODAZ HİLMİ,KARABULUT SENEM,TOZKIR HİLMİ,TANRIVERDİ ÖZGÜR,ÇABUK DEVRİM,TÜRKMEN ESMA,HACIBEKİROĞLU İLHAN,UZUNOĞLU SERNAZ,ÇİÇİN İRFAN
Parotis Bezi Metastazı ile Tanı Alan Akciğer Kanseri Olgusu - HACIBEKİROĞLU İLHAN,TÜRKMEN ESMA,KODAZ HİLMİ,HACIBEKİROĞLU TUBA,ÇİÇİN İRFAN
Kontrastlı Bilgisayarlı Tomografi Çekimi Sonrası Kontrast Madde Nefropatisi Gelişme Riski Ve Prediktif Faktörler - EMRAH GÜLŞEN,ERDOĞAN BÜLENT,TÜRKMEN ESMA,UZUNOĞLU SERNAZ,ÜSTÜNDAĞ SEDAT,TEKBAŞ SERAP,ÇİÇİN İRFAN
Kitaplar
HR pozitif HER2 negatif meme kanserinde tedaviler ve güncel yakşaımlar – Türkiye Klinikleri
Clinical Research at MENA, Challenges and Solutions – PETER LANG
Geriatrik Onkoloji – Türkiye Klinikleri
Prostat Kanseri Yönetimi – EMA Tıp Kitabevi Yayıncılık Tic. Ltd. Şti.
Son Dönem Kanser Hastasında Nütrisyonel Tedavi – Türkiye Klinikleri
KANSER VE COVID-19 PANDEMİSİ – Türkiye Klinikleri
İmmunoterapilerde Yan Etki Yönetimi – Türkiye Klinikleri
İmmünoterapilerde Yan Etki Yönetimi – Türkiye Klinikleri
Biyoteknolojik İlaçlar – AİFD
Biyoteknolojik İlaçlar – AİFD
Biyoteknolojik İlaçlar – AİFD
Biyoteknolojik İlaçlar – AİFD
Breast Cancer, A Guide to Clinical Practice – springer
Textbook of Gastrointestinal Oncology – springer
Breast DiseaseManagement and Therapies – springer
Breast Cancer A Guide to Clinical Practice – springer
İleri Evre Mide Kanserinde Tedavi Yaklaşımlar – Türkiye Klinikleri
GEBELİKTE SARKOM TEDAVİSİ – GÜNEŞ TIP KİTAPEVİ
Gebelikte Kanser Tedavisi – Güneş Tıp Kitapevleri
İLERİ EVREKÜÇÜK HÜCRELİ DIŞIAKCİĞER KANSERİTANI VE TEDAVİ KILAVUZU – Güneş
